Clinical Trials Logo

Healthy Volunteers clinical trials

View clinical trials related to Healthy Volunteers.

Filter by:

NCT ID: NCT01555918 Completed - Healthy Volunteers Clinical Trials

A Study to Assess the Safety and Pharmacokinetics of Isavuconazole in Healthy Chinese Volunteers

Start date: August 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the pharmacokinetic properties of isavuconazole (BAL4815) and the cleavage product (BAL8728) and assess the safety and tolerability after single-dose and steady state (multiple-dose) administration of isavuconazole BAL8557 in healthy Chinese subjects.

NCT ID: NCT01555866 Completed - Healthy Volunteers Clinical Trials

Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.

Start date: March 2012
Phase: Phase 1
Study type: Interventional

This is a 2-part, open-label study, designed to evaluate the effect of renal disease on the pharmacokinetics of BAL4815 (active isavuconazole moiety) relative to the pharmacokinetics in healthy subjects with normal renal function.

NCT ID: NCT01551836 Completed - Healthy Volunteer Clinical Trials

At What Time Therapeutic Plasma Concentrations of Paracetamol Are Achieved in Two Marketed Formulations

Start date: June 2009
Phase: Phase 1
Study type: Interventional

This will be a single centre, open label, randomised, two-way crossover study in healthy volunteers under semi-fed conditions. Two formulations of paracetamol, are being tested in this study to establish at what time point a therapeutic concentration of paracetamol in the blood is reached. Subjects will attend a screening visit to check if they are eligible for study participation then within 15 days they will check-in to the unit for a stay of approximately 48 hours (hrs). They will be given a single dose of one of the preparations on the first day and then the other preparation on the next day. Regular blood samples will be taken along with other assessments for safety.

NCT ID: NCT01549106 Completed - Healthy Volunteers Clinical Trials

IPI-145 Single Ascending, Multiple Ascending, Food Effect and Drug-Drug-Interaction Study

Start date: August 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of IPI-145 after single and repeat oral administration, and to evaluate the effects of food and ketoconazole on the plasma pharmacokinetics of IPI-145.

NCT ID: NCT01545765 Completed - Healthy Volunteers Clinical Trials

Anesthetic Effect Duration Assessment

Start date: May 2012
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the duration of anesthetic effect produced , Lidocaine7% + Tetracaine 7% cream when applied with 2 different application times on the face and thigh.

NCT ID: NCT01545583 Completed - Healthy Volunteers Clinical Trials

A Study of LY3016859 in Healthy Volunteers

Start date: April 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate the safety and tolerability of LY3016859 administered as single doses, and to determine how long LY3016859 remains in the body

NCT ID: NCT01544348 Completed - Healthy Volunteers Clinical Trials

A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL

Start date: January 2012
Phase: Phase 1
Study type: Interventional

Phase 1 study to evaluate the safety of MEDI4212.

NCT ID: NCT01544140 Completed - Healthy Volunteers Clinical Trials

Study in Healthy Volunteers to Assess the Pharmacokinetics of Midazolam Administered Alone and in Combination With Vandetanib

Vandetanib
Start date: April 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study in healthy volunteers is to assess the Pharmacokinetics (PK) of Midazolam administered alone and in combination with Vandetanib.

NCT ID: NCT01543529 Completed - Healthy Volunteer Clinical Trials

A Pharmacodynamic and Pharmacokinetic Study of RO4917838 in Healthy Volunteers

Start date: February 28, 2012
Phase: Phase 1
Study type: Interventional

This single-center, randomized, double-blind, four-period crossover study will investigate the effect of alcohol on the pharmacodynamics and pharmacokinetics of RO4917838 in healthy volunteers. Healthy volunteers will receive 4 treatments in a randomized order: single dose of RO4917838 and alcohol, RO4917838 and non-alcoholic drink, placebo to RO4917838 and alcohol, and placebo to RO4917838 and non-alcoholic drink.

NCT ID: NCT01543386 Completed - Clinical trials for Healthy Volunteers (Middle-aged Smokers)

Effects of Curcumin on Vascular Reactivity

CURCUMIN
Start date: February 2012
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this study is to determine if an oral loading-dose of curcumin can improve vascular endothelium reactivity in patients with moderate cardiovascular risk